Lyra Therapeutics Inc LYRA

$0.50 +0.01 (1.01%)

Valuation

Market cap
2,343,000
Revenue TTM
$1,530,000
Net income TTM
$-93,440,000
PE ratio
0.00
Forward PE
—
Profit margin
-6,107.19%
Debt to equity
0.00

Trading

Volume
176,300
Avg volume
120,622
Day's range
$0.31 – $0.50
Shares out
1,775,000
Stochastic %K
17%
Beta
0.00
Analysts
Hold
Price target
$16.00

Price

Company profile

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable d...

Show more

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhinosinusitis (CRS); and LYR-220 for CRS patients who have failed previous medical management and continue to require treatment to manage CRS symptoms. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 393 4600
Website
https://lyratherapeutics.com
Address
480 Arsenal Way, Watertown, United States

Latest news

Stocktwits

sch177 Sep 4, 2:58 PM
$OSTX Anyone here know of $LYRA . About a year ago they took off from a company trading like $OSTX to up over $30. Instant millionaires. Prices feel back to the $7-$10 range but now some months on they are off the stock exchange and broke. Crazy. My point is - lets know when to sell if this does hit it big. I am wondering where the top of the mountain is here if it does rise? Where do we fell it'll drop to even post approval.
0 replies
ChetdaJet Aug 21, 3:34 PM
$LYRA is this still a thing??
0 replies
YouVSYou Jul 17, 5:23 PM
This was the week I was literally going to eat more lettuce 😞 $DJT I want to pay $100K a month for faster trump front loads wbu $SPY $OKLO $LYRA $ASTS reversals on deck
0 replies
TwongStocks Apr 17, 12:09 PM
$LYRA Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC https://investors.lyratherapeutics.com/news-releases/news-release-details/lyra-therapeutics-inc-announces-intention-voluntarily-file-form It is already trading OTC, so the Form 25 filing is a formality. However, after the Form 25 is effective, they intend to file a Form 15. This will terminate its registration with the SEC. The company will no longer be subject to SEC reporting requirements after the Form 15 filing. They won't be required to make any more 10-K, 10-Q, or 8-K filings after the Form 15 is effective.
1 replies
focafoca99 Apr 10, 6:09 PM
$LYRA agreed to terminate part of its Watertown lease early, forfeiting its security deposit and paying $1.X million to exit the space sooner.
0 replies
Fishintheocean Apr 6, 10:03 PM
$LYRA anyone still holding? Holding 563 shares @ .3501 still… can’t hurt
0 replies
ProfProfit Mar 20, 8:12 PM
$LYRA I sold this off at $30 last June. What the fuck happened to it???
0 replies
TwongStocks Mar 17, 12:06 PM
$LYRA Begins trading on pink sheets today https://www.otcmarkets.com/stock/LYRA/overview
0 replies